Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Sep. 30, 2020	Jun. 30, 2020
Current assets
Cash and cash equivalents	$ 860	$ 871
Receivables, net	685	648
Inventories, net	534	454
Prepaid expenses and other current assets	65	47
Total current assets	2,144	2,020
Property, plant and equipment, net of accumulated depreciation and amortization of $2,270 and $2,224, respectively	1,176	1,103
Operating lease right-of-use assets	281	291
Goodwill	1,793	1,577
Trademarks, net	786	785
Other intangible assets, net	265	109
Other assets	332	328
Total assets	6,777	6,213
Current liabilities
Current operating lease liabilities	64	64
Accounts payable and accrued liabilities	1,395	1,329
Income taxes payable	57	25
Total current liabilities	1,516	1,418
Long-term debt	2,781	2,780
Long-term operating lease liabilities	268	278
Other liabilities	797	767
Deferred income taxes	104	62
Total liabilities	5,466	5,305
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 158,741,461 shares issued as of September 30, 2020 and June 30, 2020; and 126,037,019 and 126,198,606 shares outstanding as of September 30, 2020 and June 30, 2020, respectively	159	159
Additional paid-in capital	1,146	1,137
Retained earnings	3,840	3,567
Treasury shares, at cost: 32,704,442 and 32,542,855 shares as of September 30, 2020 and June 30, 2020, respectively	(3,407)	(3,315)
Accumulated other comprehensive net (loss) income	(623)	(640)
Total Clorox stockholders’ equity	1,115	908
Noncontrolling interests	196	0
Total stockholders’ equity	1,311	908
Total liabilities and stockholders’ equity	$ 6,777	$ 6,213